Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZORRO: Zoledronic Acid for Healing After Arthroscopic Repair of Chronic Rotator Cuff Lesions
NCT05677152Phase 2Active, not recruiting
- Sponsor
- AUVA-Traumazentrum Wien, Standort Meidling
- Start
- Aug 2022
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in rotator cuff tear, sponsored by AUVA-Traumazentrum Wien, Standort Meidling. Started Aug 2022; status: active, not recruiting.
02
Drugs
zoledronic acid
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT05677152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05677152.